SurModics Announces Resignation of Jeffrey Smith from the Board of Directors
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced that effective August 27, 2012, Mr. Jeffrey Smith has resigned from SurModics' Board of Directors.
“Upon joining SurModics' Board of Directors in January of 2011, my goal was to work collaboratively with my fellow directors and the management team to create and enhance value for all shareholders,” commented Jeffrey Smith. “These objectives have been successfully accomplished as demonstrated by SurModics' strong financial results. As a result, the Company is well-positioned to continue to drive profitable core organic revenue growth."
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.